Alpine Global Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Alpine Global Management’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-66,402	Closed	-$147K	–	269
2023 Q2	$147K	Buy	+66,402	New	+$138K	0.04%	164

Alpine Global Management's PRTK Position: Q3 2023 in Review

Alpine Global Management sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 66,402 shares — an estimated $147K sold.

Alpine Global Management first reported a position in PRTK in Q2 2023 and held it in 1 quarter. The position peaked at $147K in Q2 2023. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.

Alpine Global Management reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Alpine Global Management sold 66,402 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $147K.
Alpine Global Management first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2023 and held it in 1 quarter.
Alpine Global Management's Paratek Pharmaceuticals, Inc. position peaked at $147K in Q2 2023.
0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.

Based on Alpine Global Management's 13F filing for Q3 2023, filed 14 Nov 2023.